Search Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapySolid TumorsProtocol groupHead and Neck OncologyradiotherapyDiseaseHead and Neck Tumors (Squamous Cell)Nasopharyngeal CarcinomaSubgroupICD10C11.-C11.8C11.9C76.0MeSHHypopharyngeal NeoplasmsLaryngeal NeoplasmsMouth NeoplasmsNasopharyngeal CarcinomaOropharyngeal NeoplasmsSquamous Cell Carcinoma of Head and NeckSequenceCETU400/PACL40/CRBP2/Radiation, Head and Neck Tumors, C1 (PID622) -|- CETU250/PACL40/CRBP2/Radiation, Head and Neck Tumors, C2+ (PID621)CETU400/PACL90/CRBP2, Head and Neck Tumors, C1 (PID1242) -|- C2-6 (PID1243) -|- C7-11 (PID1244)CISP100/Radiatio, Head and Neck Tumors (PID1334) -|- CISP100/CAPE1000, Nasopharyngeal Ca (PID1784).CISP100/Radiation, Nasopharyngeal Ca, A (PID1714) -|- CISP80/FU1000, Nasopharyngeal Ca, B (PID1707)CRBP100/Radiation, Nasopharyngeal Ca, A (PID1781) -|- CRBP5/FU1000, Nasopharyngeal Ca, B (PID1782)DOCE60/CISP60/FU600, Nasopharyngeal Ca (PID1373) -|- CISP100/Radiation, Head and Neck Tumors (PID1334)DOCE75/CISP75/FU750 - CISP40/Radiation, Nasopharyngeal Ca, A (PID1099) -|- B (PID1101)GEMC1000/CISP80, Nasopharyngeal Ca (PID1325) -|- CISP100/Radiation (PID1334)ChemotherapyChemo-substanceCapecitabineCarboplatinCetuximabCisplatinDocetaxelFluorouracilOxaliplatinPaclitaxelChemo-substanceCapecitabineCarboplatinCetuximabCisplatinDocetaxelFluorouracilOxaliplatinPaclitaxelChemo-substanceCapecitabineCarboplatinCetuximabCisplatinDocetaxelFluorouracilOxaliplatinPaclitaxelChemo-substanceCapecitabineCarboplatinCetuximabCisplatinDocetaxelFluorouracilOxaliplatinPaclitaxelNo. Substances123 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionCimetidineDexamethasoneDimetindenFosaprepitantGranisetronHydrocortisoneMagnesiumMagnesium sulfateMinocyclinePegfilgrastimPotassium chlorideSupportive substanceBalanced Crystalloid SolutionCimetidineDexamethasoneDimetindenFosaprepitantGranisetronHydrocortisoneMagnesiumMagnesium sulfateMinocyclinePegfilgrastimPotassium chlorideSupportive substanceBalanced Crystalloid SolutionCimetidineDexamethasoneDimetindenFosaprepitantGranisetronHydrocortisoneMagnesiumMagnesium sulfateMinocyclinePegfilgrastimPotassium chlorideSupportive substanceBalanced Crystalloid SolutionCimetidineDexamethasoneDimetindenFosaprepitantGranisetronHydrocortisoneMagnesiumMagnesium sulfateMinocyclinePegfilgrastimPotassium chlorideNo. Substances2345678Protocol classificationTherapy classificationalternativecurrent standardIntensityStandard doseTherapy indicationFirst lineTherapy phaseInductionTherapy intentioncurativepalliativeRisksAllergic ReactionAnemia Hb below 8g/dlAstheniaDiarrheaDysphagiaEmetogenicity (ASCO)Emetogenicity (MASCC/ESMO)EsophagitisFatigueFebrile NeutropeniaHepatotoxicityHypomagnesemiaHyponatremiaInfectionsLeukopeniaMucositisMyositisNauseaNephrotoxicityNeuropathyNeutropeniaOral MucositisOtotoxicityPneumoniaRadiation DermatitisRashRenal FailureThrombocytopenia below 50 000/µlThromboembolic Event only studiesPublicationAuthorAdelstein DChitapanarux IFrikha MHaddad RLee ALee AWMMedina JAPatil VMSuntharalingam MSun YWanebo HYou RZhang LDiseasefortgeschrittenes Nasopharynxkarzinom, T1-4N2-3M0, ECOG 0-2Kopf-Hals-Tumoren (Plattenepithel-), resektabel, Stadium III-IV, ECOG 0-1Kopf-Hals-Tumoren, cTx cNx cM0, nicht cisplatingeeignet, ECOG 0-2Kopf-Hals-Tumoren, nicht resektabel, UICC Stadium III/IV, ECOG 0-1Lokal fortgeschrittene Kopf-Hals-Tumoren, cT2 oder höher und N2–N3b nach AJCC 1997, ECOG 0-2lokal fortgeschrittenes, nicht reserzierbares Plattenepithel-Karzinom des Kopf/Halses, Stadium III-IV,M0 Erstlinie, Karnofsky >70Lokal fortgeschrittenes Nasopharynx-Ca, Tx und N2/N3 oder T3/T4 und Nx, ECOG 0-2Lokal fortgeschrittenes NasopharynxkarzinomLokal fortgeschrittenes Nasopharynxkarzinom Metastasiertes Nasopharynxkarzinom, CR oder PR nach 3 Zyklen Chemotherapie mit Cisplatin/5-FU, ECOG 0-2Nasopharynx-Ca, Stadium III-IVb, ECOG0-2Nasopharynxkarzinom, Stadium III-IVB, Erstlinieneudiagnostizierter, lokal fortgeschrittener Kopf-Hals-Tumor, Stadium III-IV, Plattenepithel-, ECOG 0-1Nicht resezierbare Kopf-Hals-Tumoren (Plattenepithel-), Stadium III - IV, ECOG 0-1OriginCancer Center of Sun Yat-Sen University, Guangzhou, People's Republic of ChinaChiang Mai University, Chiang Mai, ThailandCleveland Clinic Foundation, ClevelandDepartment of Clinical Oncology, The University of Hong Kong, NPC‐0501 trialDepartment of Radiation Oncology, Sun Yatsen University Cancer Centre, ChinaDepartment of Radiation Oncology, University of Maryland School of Medicine, Baltimore BDDepartment of Surgery, Landmark Medical Center, Woonsocket, ECOG-ACRIN trial (E2303)Head and Neck Oncology, Dana Farber Cancer Institute, arvard Medical School, Boston, MassachusettsMedical Oncology department, University Hospital, Sfax (Tunisia), GORTEC 2006-02NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study GroupServicio de Oncologia Radioterapica, Hospital Clinico Universitario, Malaga, SpainSun Yat-sen University Cancer Center, Guangzhou, ChinaTata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, IndiaProtocols in Revision 17 protocols foundProtocols under revision.Carboplatin 100 / Radiation, Nasopharyngeal Carcinoma, Part A (PID1781 V1.0)Carboplatin 5 / Fluorouracil 1000, Nasopharyngeal Carcinoma, Part B (PID1782 V1.0)Cetuximab 250 / Paclitaxel 30 / Carboplatin 1 / Radiation, Head and Neck Tumors, Cycle 7-11 (PID1244 V1.1)Cetuximab 250 / Paclitaxel 40 / Carboplatin 2 / Radiation, Head and Neck Tumors, Cycle 2+ (PID621 V1.1)Cetuximab 400 / Paclitaxel 40 / Carboplatin 2 / Radiation, Head and Neck Tumors, Cycle 1 (PID622 V1.1)Cisplatin 100 / Capecitabine 1000, Nasopharyngeal Carcinoma (PID1784 V1.2)Cisplatin 100 / Fluorouracil 1000 / Radiation, Nasopharyngeal Carcinoma (PID1737 V1.1)Cisplatin 100 / Radiation, Head and Neck Tumors (PID1334 V1.1)Cisplatin 100 / Radiation, Nasopharyngeal Carcinoma, Part A (PID1714 V1.1)Cisplatin 40 / Radiation, Head and Neck Tumors (PID1637 V1.1)Cisplatin 80 / Fluorouracil 1000, Nasopharyngeal Carcinoma, Part B (PID1707 V1.1)Docetaxel 15 / Radiatio, Head and Neck Tumors (PID2259 V1.0)Docetaxel 60 / Cisplatin 60 / Fluorouracil 600, Nasopharyngeal Carcinoma (PID1373 V1.1)Docetaxel 75 / Cisplatin 75 / Fluorouracil 750 - Cisplatin 40 / Radiation, Nasopharyngeal Carcinoma, Part A (PID1099 V1.1)Docetaxel 75 / Cisplatin 75 / Fluorouracil 750 - Cisplatin 40 / Radiation, Nasopharyngeal Carcinoma, Part B (PID1101 V1.1)Oxaliplatin 70 / Radiation, Nasopharyngeal Carcinoma (PID1783 V1.0)Paclitaxel 45 / Carboplatin 1.5 / Radiation, Head and Neck Tumors (PID1295 V1.1)
